CSI Market
Sign In | Register

Oncotelic Therapeutics Inc (OTLC) Annual Balance Sheets

Annual · GAAP · USD millions
Access OTLC quarterly Balance Sheets →
This page allows investors to track Oncotelic Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.09
Cash & Short-term Investments0.00
Accounts receivable0.05
Other Current Assets0.02
Prepaid Expense And Other Assets Current1.04
Total Current Assets1.20
Equipment/Property/Plant Net1.10
Goodwill net2.79
Intangible Assets0.00
Prepaid Expense and Other Assets, Total0.00
Other Assets, Noncurrent388.00
Restricted Cash0.02
Total Assets393.09
Liabilities
Accounts Payable2.92
Derivative Liability, Current DE0.35
Notes Payable, Current NO4.02
Other Liabilities, Current8.23
Business Combination, Contingent Consideration, Liability, Current BU2.63
Total Current Liabilities18.14
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Gross DE111.55
Other liabilities, Noncurrent1.66
Convertible Debt And Short Term Debt Related Party Current0.00
Private Placement Convertible Debt Related Party Net Of Costs0.00
Total Liabilities131.36
Stockholders' Equity
Common Stock Value4.43
Additional Paid In Capital Common Stock47.10
Retained Earnings / Accumulated Deficit211.24
Other Equity0.00
Common Stockholder's Equity262.76
Preferred Stockholder's Equity0.00
Non-controlling interests & other-1.03
Total Stockholder's Equity261.73
Liabilities & Stockholder's Equity393.09
4 historic quarters locked

Sign in to unlock the full Oncotelic Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Oncotelic Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-016838

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License